| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 11 |
| 1 | ASPIRIN | 9 |
| 2 | ASPIRIN 325 MG | 9 |
| 3 | ASPIRIN 81 MG | 9 |
| 4 | METHOTREXATE SODIUM | 9 |
| 5 | METHOTREXATE | 8 |
| 6 | ETANERCEPT | 7 |
| 7 | OMEPRAZOLE | 7 |
| 8 | OMEPRAZOLE MAGNESIUM | 7 |
| 9 | AMLODIPINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 2 | 0.0013 |
| 1 | CEFTAROLINE FOSAMIL | 1 | 0.0012 |
| 2 | ZAFIRLUKAST | 1 | 0.0011 |
| 3 | ALPROSTADIL | 3 | 0.0008 |
| 4 | IRON DEXTRAN | 1 | 0.0007 |
| 5 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 7 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 8 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 9 | BROLUCIZUMAB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 5 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 3 | 0.0001 |
| 8 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |